Ceapro Inc. (CVE:CZO – Get Free Report) shares fell 11.8% during mid-day trading on Tuesday . The company traded as low as C$0.23 and last traded at C$0.23. 5,849 shares changed hands during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The stock has a fifty day moving average price of C$0.22 and a 200-day moving average price of C$0.23. The company has a current ratio of 8.54, a quick ratio of 18.88 and a debt-to-equity ratio of 8.07. The firm has a market capitalization of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
See Also
- Five stocks we like better than Ceapro
- How to Most Effectively Use the MarketBeat Earnings Screener
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Insider Buying Signals Upside for These 3 Stocks
- What is the Shanghai Stock Exchange Composite Index?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
